백일해 백신 시장 보고서 : 동향, 예측, 경쟁 분석(-2030년)

Pertussis Vaccine Trends and Forecast

The future of the global pertussis vaccine market looks promising with opportunities in the vaccination center, hospital, and clinic markets. The global pertussis vaccine market is expected to reach an estimated $9.1 billion by 2030 with a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are growing awareness of the importance of pertussis vaccination, supportive government initiatives to promote pertussis vaccination, and continous development of new pertussis vaccines.

A more than 150-page report is developed to help in your business decisions.

Pertussis Vaccine by Segment

The study includes a forecast for the global pertussis vaccine by type, end use, and region.

Pertussis Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Dtap Vaccine
• Tdap Vaccine

Pertussis Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Vaccination Centers
• Hospitals
• Clinics
• Others

Pertussis Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Pertussis Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pertussis vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pertussis vaccine companies profiled in this report include-

• Protein Sciences
• Glaxosmithkline
• Sanofi Pasteur
• Seqirus
• Merck Sharp & Dohme
• Novartis
• Astellas Pharma

Pertussis Vaccine Market Insights

Lucintel forecasts that Dtap will remain the larger segment due to its significant use as combinated vaccine that protects against diphtheria, tetanus, and pertussis.

North America is expected to witness highest growth over the forecast period due to increasing number of geriatric population and rising pertussis death cases in the region.

Features of the Global Pertussis Vaccine Market

Market Size Estimates: Pertussis vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Pertussis vaccine market size by type, end use, and region in terms of value ($B).

Regional Analysis: Pertussis vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the pertussis vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pertussis vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the pertussis vaccine market size?

Answer: The global pertussis vaccine market is expected to reach an estimated $9.1 billion by 2030.

Q.2 What is the growth forecast for pertussis vaccine market?

Answer: The global pertussis vaccine market is expected to grow with a CAGR of 5.6% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the pertussis vaccine market?

Answer: The major drivers for this market are growing awareness of the importance of pertussis vaccination, supportive government initiatives to promote pertussis vaccination, and continous development of new pertussis vaccines.

Q4. What are the major segments for pertussis vaccine market?

Answer: The future of the pertussis vaccine market looks promising with opportunities in the vaccination center, hospital, and clinic markets.

Q5. Who are the key pertussis vaccine market companies?

Answer: Some of the key pertussis vaccine companies are as follows:

• Protein Sciences
• Glaxosmithkline
• Sanofi Pasteur
• Seqirus
• Merck Sharp & Dohme
• Novartis
• Astellas Pharma

Q6. Which pertussis vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that Dtap will remain the larger segment due to its significant use as combinated vaccine that protects against diphtheria, tetanus, and pertussis.

Q7. In pertussis vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to increasing number of geriatric population and rising pertussis death cases in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the pertussis vaccine market by type (Dtap vaccine and Tdap vaccine), end use (vaccination centers, hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Pertussis Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Pertussis Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Pertussis Vaccine Market by Type
  • 3.3.1: Dtap Vaccine
  • 3.3.2: Tdap Vaccine
• 3.4: Global Pertussis Vaccine Market by End Use
  • 3.4.1: Vaccination Centers
  • 3.4.2: Hospitals
  • 3.4.3: clinics
  • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Pertussis Vaccine Market by Region
• 4.2: North American Pertussis Vaccine Market
  • 4.2.2: North American Pertussis Vaccine Market by End Use: Vaccination Centers, Hospitals, clinics, and Others
• 4.3: European Pertussis Vaccine Market
  • 4.3.1: European Pertussis Vaccine Market by Type: Dtap Vaccine and Tdap Vaccine
  • 4.3.2: European Pertussis Vaccine Market by End Use: Vaccination Centers, Hospitals, clinics, and Others
• 4.4: APAC Pertussis Vaccine Market
  • 4.4.1: APAC Pertussis Vaccine Market by Type: Dtap Vaccine and Tdap Vaccine
  • 4.4.2: APAC Pertussis Vaccine Market by End Use: Vaccination Centers, Hospitals, clinics, and Others
• 4.5: ROW Pertussis Vaccine Market
  • 4.5.1: ROW Pertussis Vaccine Market by Type: Dtap Vaccine and Tdap Vaccine
  • 4.5.2: ROW Pertussis Vaccine Market by End Use: Vaccination Centers, Hospitals, clinics, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Pertussis Vaccine Market by Type
  • 6.1.2: Growth Opportunities for the Global Pertussis Vaccine Market by End Use
  • 6.1.3: Growth Opportunities for the Global Pertussis Vaccine Market by Region
• 6.2: Emerging Trends in the Global Pertussis Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Pertussis Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pertussis Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Protein Sciences
• 7.2: GlaxoSmithKline
• 7.3: Sanofi Pasteur
• 7.4: Seqirus
• 7.5: Merck Sharp & Dohme
• 7.6: Novartis
• 7.7: Astellas Pharma